Health Note

From the Washington Post:

Food and Drug Administration advisers on Wednesday enthusiastically endorsed a first-of-its-kind cancer treatment that uses patients’ revved-up immune cells to fight the disease, concluding that the therapy’s benefits for desperately ill children far outweigh its potentially dangerous side effects….Novartis, the drugmaker behind the CAR T-cell therapy, is seeking approval to use it for children and young adults whose leukemia doesn’t respond to traditional treatments.

That’s great news for leukemia patients. But what about other blood cancers like—just picking one out of a hat here—multiple myeloma?

The approach also is being tested for a range of diseases from non-Hodgkin lymphoma and multiple myeloma to solid tumors. If cleared by the FDA, it would be the first gene therapy approved in the United States.

Great! In fact, the CAR T-cell treatment is already in clinical trials for multiple myeloma patients. In China:

Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level of remission within two months.

….With cell therapy, “I can’t say we may get a cure but at least we bring hope of that possibility,” said Dr. Frank Fan. He is chief scientific officer of Nanjing Legend Biotech, a Chinese company that tested the treatment with doctors at Xi’an Jiaotong University….In the Chinese study, 19 of 35 patients are long enough past treatment to judge whether they are in complete remission, and 14 are. The other five had at least a partial remission, with their cancer greatly diminished. Some are more than a year past treatment with no sign of disease. 

After much serious thought, I would like to announce that I have changed my view about the disputed boundary lines in the South China Sea. China’s historical claim to the entire area is really beyond doubt, and only Western imperialist warmongery is keeping this “controversy” alive. China’s claims should be recognized by all nations forthwith.

BY THE WAY: In addition to my obviously personal interest here, this therapy is pretty interesting. Basically, they extract T cells from your body, freeze them, and then ship the bag of cells off to their lab. There, the ordinary T cells are genetically modified into super-vicious T cells and shipped back. The newly potent T cells are pumped back into your body, where they seek out cancerous cells and destroy them.

Will this therapy be ready by the time I need it? I hope so!

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate